EBITDA for STERIS (STE)
According to STERIS's latest reported financial statements, the company's current EBITDA (TTM) is $1.36B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
STE
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$1.36B
YoY change
-3.8%
5Y CAGR
+13.0%
Peak year (2024)
$1.41B
Cumulative EBITDA
$12.52B
EBITDA history chart for STERIS (STE) from 1991 to 2025
EBITDA history table for STERIS (STE) from 1991 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $1.36B | -3.8% | ||
| 2024 | $1.41B | +5.1% | ||
| 2023 | $1.34B | +33.1% | ||
| 2022 | $1.01B | +30.4% | ||
| 2021 | $773.95M | +5.1% | ||
| 2020 | $736.27M | +15.0% | ||
| 2019 | $639.97M | +9.6% | ||
| 2018 | $583.94M | +39.9% | ||
| 2017 | $417.31M | +16.5% | ||
| 2016 | $358.33M | +12.1% | ||
| 2015 | $319.55M | +13.0% | ||
| 2014 | $282.80M | -9.3% | ||
| 2013 | $311.86M | +9.0% | ||
| 2012 | $286.08M | +104.0% | ||
| 2011 | $140.21M | -46.3% | ||
| 2010 | $261.20M | +10.8% | ||
| 2009 | $235.82M | +16.9% | ||
| 2008 | $201.78M | -1.3% | ||
| 2007 | $204.54M | +6.0% | ||
| 2006 | $192.93M | +0.2% | ||
| 2005 | $192.54M | +8.5% | ||
| 2004 | $177.44M | +3.0% | ||
| 2003 | $172.28M | +35.1% | ||
| 2002 | $127.50M | +8.7% | ||
| 2001 | $117.32M | +69.1% | ||
| 2000 | $69.38M | -59.1% | ||
| 1999 | $169.70M | +24.0% | ||
| 1998 | $136.90M | +35.7% | ||
| 1997 | $100.90M | +12.7% | ||
| 1996 | $89.50M | +6.2% | ||
| 1995 | $84.30M | +869.0% | ||
| 1994 | $8.70M | +222.2% | ||
| 1993 | $2.70M | +1250.0% | ||
| 1992 | $200,000 | -50.0% | ||
| 1991 | $400,000 | — |
EBITDA values are taken from STERIS's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, STERIS (STE) reported EBITDA of $1.36B – edged down 3.8% year-over-year.
Across 2020–2025 (5 years), STERIS EBITDA produced a CAGR of +13.0% – with the latest reading among the more recent periods of the dataset.
STERIS EBITDA peaked at $1.41B in 2024; the latest annual figure is $1.36B in 2025 (3.8% below peak).
2024 marks the peak EBITDA at $1.41B, with the historical low of $200,000 recorded in 1992.
STERIS (STE) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $24.21B.
STERIS EBITDA by Year
STERIS EBITDA 2025: $1.36B
STERIS EBITDA in 2025 was $1.36B, edged down 3.8% below 2024.
STERIS EBITDA 2024: $1.41B
STERIS EBITDA in 2024 was $1.41B, grew 5.1% from 2023. This figure represents the highest annual value in the available history.
STERIS EBITDA 2023: $1.34B
STERIS EBITDA in 2023 was $1.34B, surged 33.1% from 2022.
STERIS EBITDA 2022: $1.01B
STERIS EBITDA in 2022 was $1.01B, surged 30.4% from 2021.
STERIS EBITDA 2021: $773.95M
STERIS EBITDA in 2021 was $773.95M.
See more financial history for STERIS (STE).
Sector peers — EBITDA
Companies in the same sector as STERIS, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is STERIS's EBITDA?
- Latest reported EBITDA for STERIS (STE) is $1.36B (period ending December 31, 2025).
How has STERIS EBITDA changed year-over-year?
- STERIS (STE) EBITDA changed -3.8% year-over-year on the latest annual filing.
What is the long-term growth rate of STERIS EBITDA?
- STERIS (STE) EBITDA compound annual growth rate is +13.0% over the most recent 5 years available.
When did STERIS EBITDA hit its highest annual value?
- STERIS EBITDA reached its highest annual value of $1.41B in 2024.
What was STERIS EBITDA in 2024?
- STERIS (STE) EBITDA in 2024 was $1.41B.
What was STERIS EBITDA in 2025?
- STERIS (STE) EBITDA in 2025 was $1.36B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
STE Overview
Company profile, financial tools, and key metrics
STE Revenue Counter
Earns $184.81 every second. See per minute, hour, and day.
STE Earnings Counter
Earns $22.44 per second net profit. See per minute, hour, and day.
STE Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
STE What If Invested
What if you had invested $1,000? See historical returns from any date.
STE How It Makes Money
Discover visual breakdown of $5.83B in revenue — where it comes from and where it goes.
STE Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
STE Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
STE Daily Price Character
Balanced · 49.9% historical win rate (green days). Streaks & record days.
STE Buybacks
0.83% TTM buyback yield. Shareholder yield & SBC comparison.
STE Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.
STE Dividend Profile
Yield: 1.16%. Safety: 7/7. See full history.
STE Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
STE Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.